interleukin-8
Showing 1 - 25 of >10,000
Endodontically Treated Teeth Trial in Cairo (Intracanal Diode laser irradiation, Placebo)
Completed
- Endodontically Treated Teeth
- Intracanal Diode laser irradiation
- Placebo
-
Cairo, EgyptFaculty of Dentistry
Nov 15, 2022
Radiation-Induced Mucositis, Head Neck Cancer Trial in Baghdad (Curcumin Gel, Standard Preparation)
Completed
- Radiation-Induced Mucositis
- Head and Neck Cancer
- Curcumin Gel
- Standard Preparation
-
Baghdad, IraqNuclear medicine and radiation therapy hospital
Aug 4, 2023
Nitrates and IL-8 in Barrett's Esophagus
Enrolling by invitation
- Barrett Esophagus
- Esophageal Adenocarcinoma
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 31, 2022
Solid Tumor, Sars-CoV2, Hematological Malignancy Trial in New York (BMS-986253)
Terminated
- Solid Tumor
- +2 more
-
New York, New YorkColumbia University Irving Medical Center
Nov 18, 2021
Zonulin and Interleukin-8 Levels and Postoperative Delirium
Not yet recruiting
- Postoperative Delirium
- Evaluation of Delirium development
- (no location specified)
May 4, 2021
Serum Interleukin 6 and 8 in Children With Acute Gastroenteritis
Recruiting
- Acute Gastroenteritis
- Acute Diarrhea
- Evaluation of serum levels of IL-6 and IL-8
-
Sohag, EgyptSohag University Hospital
Jan 15, 2022
Periodontitis Trial in Rize (biochemical analysis)
Completed
- Periodontitis
- biochemical analysis
-
Rize, TurkeyRecep Tayyip Erdogan University
Oct 18, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in
Not yet recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Biospecimen Collection
- +8 more
-
Kansas City, KansasUniversity of Kansas Cancer Center
Nov 27, 2023
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Atlanta (Aldesleukin,
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Aldesleukin
- Pembrolizumab
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Aug 8, 2022
COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)
Active, not recruiting
- COL6A3 Positive
- +3 more
- Aldesleukin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor
Recruiting
- Idiopathic Multicentric Castleman's Disease
- Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
- +2 more
-
Beijing, China
- +2 more
Apr 26, 2022
Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+
Active, not recruiting
- Metastatic Malignant Neoplasm in the Liver
- Metastatic Uveal Melanoma
- Aldesleukin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in
Recruiting
- Advanced Bladder Urothelial Carcinoma
- +23 more
- Atezolizumab
- +2 more
-
Riverside, California
- +8 more
Jul 16, 2022
Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Tumor Trial in Houston (DNA
Active, not recruiting
- Human Papillomavirus-16 Positive
- +20 more
- DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
- Durvalumab
-
Houston, TexasM D Anderson Cancer Center
Feb 11, 2022
HIV Trial in Pittsburgh (Zidovudine, Aldesleukin)
Completed
- HIV Infections
-
Pittsburgh, PennsylvaniaUniv of Pittsburgh Med School
Oct 26, 2021
Neuroblastoma Trial in New York (3F8 Monoclonal Antibody Combined with Interleukin-2)
Completed
- Neuroblastoma
- 3F8 Monoclonal Antibody Combined with Interleukin-2
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 26, 2021
Intracerebral Haemorrhage Trial in Manchester (IL-1Ra Kineret®, IL-1Ra Placebo)
Completed
- Intracerebral Haemorrhage
- IL-1Ra Kineret®
- IL-1Ra Placebo
-
Manchester, North West, United KingdomSalford Royal NHS Foundation Trust
Oct 4, 2021
COVID-19, Lymphocytopenia Trial in United Kingdom (Interleukin-7, Placebos)
Terminated
- COVID-19
- Lymphocytopenia
- Interleukin-7
- Placebos
-
Birmingham, United Kingdom
- +12 more
Mar 30, 2022
Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)
Active, not recruiting
- Metastatic Melanoma
- Stage IV Cutaneous Melanoma AJCC v6 and v7
- Aldesleukin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,
Terminated
- Acute Myeloid Leukemia
- +4 more
- Aldesleukin
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 15, 2021
Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal
Active, not recruiting
- Platinum-Resistant Fallopian Tube Carcinoma
- +11 more
- Aldesleukin
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 13, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +41 more
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 11, 2022
HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Myxoid Liposarcoma Trial in Houston
Active, not recruiting
- HLA-A*0201 Positive Cells Present
- +3 more
- Aldesleukin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Cancer, Solid Tumor Trial in Houston (drug, biological, diagnostic test)
Completed
- Cancer
- Solid Tumor
- Fludarabine
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 14, 2022
